CD44 and breast cancer: Breast cancer cells with the CD44+/CD24− phenotype were enriched for tumor-initiating CSCs and were highly invasive (6–8), and the prevalence of CD44+/CD24− tumor cells in breast cancer may favor distant metastasis (9).